Tiga TX

Boston, United States

Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.

$35.5M raised

Dec 2024

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Tiga TX raised?

Tiga TX has raised $35.5M in total funding. The most recent round was Grant. The last funding was announced in December 2024.

Who are Tiga TX's investors?

Tiga TX's investors include Advanced Research Projects Agency for Health, BioGeneration Ventures, National Cancer Institute.

Where is Tiga TX headquartered?

Tiga TX is headquartered in Boston, United States.

What does Tiga TX do?

Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.

What stage is Tiga TX at?

Tiga TX is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 18, 2024.

MLA

"Tiga TX — Funding & Investors." VCBacked, December 18, 2024, https://www.vcbacked.co/company/tiga-tx. Accessed July 4, 2026.

APA

VCBacked. (2024). Tiga TX — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/tiga-tx

Wikipedia (cite web)

{{cite web |title=Tiga TX — Funding & Investors |url=https://www.vcbacked.co/company/tiga-tx |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 18, 2024.